Bringing a p53 hotspot mutation into reach of a T cell engager

Mutations in TP53 occur across many cancers, yet the intracellular location of the p53 protein makes it difficult to target with traditional antibody-based therapies. However, mutant peptides, including those derived from p53, can be displayed by human leukocyte antigen (HLA) molecules on the cancer cell surface as peptide-HLA (pHLA) complexes, offering a route to selectively target intracellular mutant proteins. While potentially attractive, these pHLA complexes are often scarce on tumor cells and differ from their normal counterparts by only one amino acid, making selective recognition technically challenging.

Authors

Institutions

Publication Details

Journal
Molecular Therapy Oncology
Published
2026-11-18
DOI
https://doi.org/10.1016/j.omton.2026.201379
Primary Topic
Immunotherapy and Immune Responses
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Bringing a p53 hotspot mutation into reach of a T cell engager

Jacqueline Douglass
3 links
Molecular Therapy Oncology
Immunotherapy and Immune Responses
article

Bringing a p53 hotspot mutation into reach of a T cell engager

Jacqueline Douglass
article en

Abstract

Mutations in TP53 occur across many cancers, yet the intracellular location of the p53 protein makes it difficult to target with traditional antibody-based therapies. However, mutant peptides, including those derived from p53, can be displayed by human leukocyte antigen (HLA) molecules on the cancer cell surface as peptide-HLA (pHLA) complexes, offering a route to selectively target intracellular mutant proteins. While potentially attractive, these pHLA complexes are often scarce on tumor cells and differ from their normal counterparts by only one amino acid, making selective recognition technically challenging.

Molecular Therapy OncologyVol. 34(4)
Howard Hughes Medical Institute (US), Johns Hopkins University (US), Johns Hopkins Medicine (US), Sidney Kimmel Comprehensive Cancer Center (US)
American Society of Clinical Oncology, National Cancer Institute
Good health and well-being
Immunotherapy and Immune Responses
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon